Insider Trading March 13, 2026 11:31 AM

Peoples Bancorp Director Disposes $59,446 in Shares; Bank Posts Modest Beat on EPS

Director Carol A. Schneeberger reduces stake while the bank reports a steady quarter and DA Davidson maintains a Buy rating

By Marcus Reed PEBO

Carol A. Schneeberger, a director at Peoples Bancorp Inc (PEBO), sold 1,895 shares on March 11, 2026, for $31.37 apiece, netting $59,446. Following the sale she directly holds 19,309 shares. The bank reported a fourth-quarter 2025 net income increase and slightly beat EPS expectations, while DA Davidson reiterated a Buy rating with a $35.00 target.

Peoples Bancorp Director Disposes $59,446 in Shares; Bank Posts Modest Beat on EPS
PEBO

Key Points

  • Director Carol A. Schneeberger sold 1,895 shares on March 11, 2026, for $31.37 each, totaling $59,446; she retains 19,309 shares directly.
  • Peoples Bancorp reported Q4 2025 net income of $31.8 million, up from $26.9 million a year earlier, and delivered EPS of $0.89 versus a $0.88 forecast.
  • The bank trades at $31.64 with a $1.12 billion market cap, a P/E of 10.58, a 5.15% dividend yield, and InvestingPro's Fair Value analysis flags the stock as overvalued.

Stock sale details

Carol A. Schneeberger, serving on the board of Peoples Bancorp Inc (NASDAQ: PEBO), executed a sale of 1,895 common shares on March 11, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The transaction was completed at $31.37 per share, producing total proceeds of $59,446. After the disposition, Schneeberger's direct holdings in Peoples Bancorp amount to 19,309 shares.

Market and valuation snapshot

At the time of the filing, Peoples Bancorp's stock was trading at $31.64. The company's market capitalization stood at $1.12 billion and the reported price-to-earnings ratio was 10.58. InvestingPro data cited in the filing shows the bank offers a dividend yield of 5.15% and has sustained dividend payments for 53 consecutive years. The same platform's Fair Value analysis indicates the shares are currently overvalued, with additional detail available through its Pro Research Reports.

Recent financial results

Peoples Bancorp disclosed results for the fourth quarter and full year of 2025. For the quarter, the bank reported net income of $31.8 million, up from $26.9 million in the year-ago quarter. Net interest income increased to $91.0 million from $86.5 million. Total non-interest income was reported at $26.3 million and total non-interest expense reached $71.3 million.

On a per-share basis, earnings came in at $0.89, narrowly topping the forecast of $0.88. Revenue for the period was $117.32 million, slightly below the expected $117.98 million.

Analyst view

DA Davidson reiterated its Buy rating on Peoples Bancorp and kept a price target of $35.00, characterizing the results as a "consistent quarter" for the bank.


This article provides a factual account of an insider transaction and the company's recent financial results based on filings and the company's published disclosures.

Risks

  • Insider sale may be interpreted variably by investors; the transaction reduces an insider's direct stake and could influence market perception of confidence in the stock - affecting equity market participants.
  • Revenue for the quarter missed expectations ($117.32 million actual versus $117.98 million expected), which is a potential uncertainty for revenue-sensitive valuations and investor sentiment in financials.
  • Fair Value analysis from InvestingPro identifies the stock as overvalued, introducing valuation risk for prospective equity investors in the banking sector.

More from Insider Trading

MapLight Therapeutics CFO Executes $1.02 Million Stock Sale Amid Clinical Milestones May 6, 2026 Travere Therapeutics Executive Executes Over $1 Million in Stock Sales May 6, 2026 Travere Therapeutics CMO Executes $1.02 Million in Stock Transactions May 6, 2026 Travere Therapeutics Director Executes $360,000 Stock Sale Under Pre-Arranged Plan May 6, 2026 Travere Therapeutics Executive Executes Stock Sale Under Pre-Arranged Plan May 6, 2026